| Year |
Citation |
Score |
| 2020 |
Châtre R, Lange J, Péraudeau E, Poinot P, Lerondel S, Le Pape A, Clarhaut J, Renoux B, Papot S. In vivo synthesis of triple-loaded albumin conjugate for efficient targeted cancer chemotherapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 32777236 DOI: 10.1016/J.Jconrel.2020.08.008 |
0.382 |
|
| 2019 |
Lange J, Eddhif B, Tarighi M, Garandeau T, Péraudeau E, Clarhaut J, Renoux B, Papot S, Poinot P. Volatile Organic Compound (VOC)-Based Probe for Induced Volatolomics of Cancers. Angewandte Chemie (International Ed. in English). PMID 31518472 DOI: 10.1002/Anie.201906261 |
0.306 |
|
| 2019 |
Taran F, Porte K, Renoux B, Peraudeau E, Clarhaut J, Eddhif B, Poinot P, Gravel E, Doris E, Wijkhuisen A, Papot S. Controlled Release of Micelle Payload via Sequential Enzymatic and Bioorthogonal Reactions in Living Systems. Angewandte Chemie (International Ed. in English). PMID 30856679 DOI: 10.1002/Anie.201902137 |
0.3 |
|
| 2018 |
Renoux B, Fangous L, Hötten C, Péraudeau E, Eddhif B, Poinot P, Clarhaut J, Papot S. A β-glucuronidase-responsive albumin-binding prodrug programmed for the double release of monomethyl auristatin E. Medchemcomm. 9: 2068-2071. PMID 30746064 DOI: 10.1039/C8Md00466H |
0.333 |
|
| 2018 |
Compain G, Oumata N, Clarhaut J, Péraudeau E, Renoux B, Galons H, Papot S. A β-glucuronidase-responsive albumin-binding prodrug for potential selective kinase inhibitor-based cancer chemotherapy. European Journal of Medicinal Chemistry. 158: 1-6. PMID 30199702 DOI: 10.1016/J.Ejmech.2018.08.100 |
0.333 |
|
| 2018 |
Koniev O, Dovgan I, Renoux B, Ehkirch A, Eberova J, Cianférani S, Kolodych S, Papot S, Wagner A. Reduction-rebridging strategy for the preparation of ADPN-based antibody-drug conjugates. Medchemcomm. 9: 827-830. PMID 30108971 DOI: 10.1039/C8Md00141C |
0.303 |
|
| 2017 |
Péraudeau E, Cronier L, Monvoisin A, Poinot P, Mergault C, Guilhot F, Tranoy-Opalinski I, Renoux B, Papot S, Clarhaut J. Enhancing tumor response to targeted chemotherapy through up-regulation of folate receptor α expression induced by dexamethasone and valproic acid. Journal of Controlled Release : Official Journal of the Controlled Release Society. 269: 36-44. PMID 29129656 DOI: 10.1016/J.Jconrel.2017.11.011 |
0.363 |
|
| 2017 |
Kolodych S, Michel C, Delacroix S, Koniev O, Ehkirch A, Eberova J, Cianférani S, Renoux B, Krezel W, Poinot P, Muller CD, Papot S, Wagner A. Development and evaluation of β-galactosidase-sensitive antibody-drug conjugates. European Journal of Medicinal Chemistry. PMID 28818506 DOI: 10.1016/J.Ejmech.2017.08.008 |
0.388 |
|
| 2017 |
Renoux B, Raes F, Legigan T, Péraudeau E, Eddhif B, Poinot P, Tranoy-Opalinski I, Alsarraf J, Koniev O, Kolodych S, Lerondel S, Le Pape A, Clarhaut J, Papot S. Targeting the tumour microenvironment with an enzyme-responsive drug delivery system for the efficient therapy of breast and pancreatic cancers. Chemical Science. 8: 3427-3433. PMID 28507714 DOI: 10.1039/C7Sc00472A |
0.362 |
|
| 2017 |
Bezagu M, Clarhaut J, Renoux B, Monti F, Tanter M, Tabeling P, Cossy J, Couture O, Papot S, Arseniyadis S. In situ targeted activation of an anticancer agent using ultrasound-triggered release of composite droplets. European Journal of Medicinal Chemistry. PMID 28416362 DOI: 10.1016/J.Ejmech.2017.03.057 |
0.342 |
|
| 2015 |
Barat R, Legigan T, Tranoy-Opalinski I, Renoux B, Péraudeau E, Clarhaut J, Poinot P, Fernandes AE, Aucagne V, Leigh DA, Papot S. A mechanically interlocked molecular system programmed for the delivery of an anticancer drug. Chemical Science. 6: 2608-2613. PMID 29308165 DOI: 10.1039/C5Sc00648A |
0.356 |
|
| 2015 |
Alsarraf J, Péraudeau E, Poinot P, Tranoy-Opalinski I, Clarhaut J, Renoux B, Papot S. A dendritic β-galactosidase-responsive folate-monomethylauristatin E conjugate. Chemical Communications (Cambridge, England). 51: 15792-5. PMID 26365722 DOI: 10.1039/C5Cc05294G |
0.372 |
|
| 2014 |
Balbous A, Renoux B, Cortes U, Milin S, Guilloteau K, Legigan T, Rivet P, Boissonnade O, Martin S, Tripiana C, Wager M, Bensadoun RJ, Papot S, Karayan-Tapon L. Selective release of a cyclopamine glucuronide prodrug toward stem-like cancer cell inhibition in glioblastoma. Molecular Cancer Therapeutics. 13: 2159-69. PMID 25053823 DOI: 10.1158/1535-7163.Mct-13-1038 |
0.316 |
|
| 2014 |
Tranoy-Opalinski I, Legigan T, Barat R, Clarhaut J, Thomas M, Renoux B, Papot S. β-Glucuronidase-responsive prodrugs for selective cancer chemotherapy: an update. European Journal of Medicinal Chemistry. 74: 302-13. PMID 24480360 DOI: 10.1016/J.Ejmech.2013.12.045 |
0.375 |
|
| 2013 |
Grinda M, Legigan T, Clarhaut J, Peraudeau E, Tranoy-Opalinski I, Renoux B, Thomas M, Guilhot F, Papot S. An enzyme-responsive system programmed for the double release of bioactive molecules through an intracellular chemical amplification process. Organic & Biomolecular Chemistry. 11: 7129-33. PMID 24057011 DOI: 10.1039/C3Ob41536H |
0.333 |
|
| 2013 |
Legigan T, Clarhaut J, Renoux B, Tranoy-Opalinski I, Monvoisin A, Jayle C, Alsarraf J, Thomas M, Papot S. Synthesis and biological evaluations of a monomethylauristatin E glucuronide prodrug for selective cancer chemotherapy. European Journal of Medicinal Chemistry. 67: 75-80. PMID 23845743 DOI: 10.1016/J.Ejmech.2013.06.037 |
0.384 |
|
| 2012 |
Legigan T, Clarhaut J, Tranoy-Opalinski I, Monvoisin A, Renoux B, Thomas M, Le Pape A, Lerondel S, Papot S. The first generation of β-galactosidase-responsive prodrugs designed for the selective treatment of solid tumors in prodrug monotherapy. Angewandte Chemie (International Ed. in English). 51: 11606-10. PMID 22996951 DOI: 10.1002/Anie.201204935 |
0.317 |
|
| 2012 |
Legigan T, Clarhaut J, Renoux B, Tranoy-Opalinski I, Monvoisin A, Berjeaud JM, Guilhot F, Papot S. Synthesis and antitumor efficacy of a β-glucuronidase-responsive albumin-binding prodrug of doxorubicin. Journal of Medicinal Chemistry. 55: 4516-20. PMID 22515366 DOI: 10.1021/Jm300348R |
0.335 |
|
| 2012 |
Grinda M, Clarhaut J, Renoux B, Tranoy-Opalinski I, Papot S. A self-immolative dendritic glucuronide prodrug of doxorubicin Med. Chem. Commun.. 3: 68-70. DOI: 10.1039/C1Md00193K |
0.327 |
|
| 2012 |
Vuong S, Brondel N, Len C, Papot S, Renoux B. Formal synthesis of TMC-69-6H via a one-pot enantioselective domino proline-mediated aldol/olefin homologation procedure Tetrahedron. 68: 433-439. DOI: 10.1016/J.Tet.2011.11.025 |
0.313 |
|
| 2011 |
Renoux B, Legigan T, Bensalma S, Chadéneau C, Muller JM, Papot S. A new cyclopamine glucuronide prodrug with improved kinetics of drug release Organic and Biomolecular Chemistry. 9: 8459-8465. PMID 22042246 DOI: 10.1039/C1Ob06081C |
0.36 |
|
| 2010 |
Hamon F, Renoux B, Chadéneau C, Muller JM, Papot S. Study of a cyclopamine glucuronide prodrug for the selective chemotherapy of glioblastoma European Journal of Medicinal Chemistry. 45: 1678-1682. PMID 20116904 DOI: 10.1016/J.Ejmech.2009.12.067 |
0.334 |
|
| 2010 |
PAPOT S, COMBAUD D, GESSON J. ChemInform Abstract: A New Spacer Group Derived from Arylmalonaldehydes for Glucuronylated Prodrugs. Cheminform. 30: no-no. DOI: 10.1002/CHIN.199902251 |
0.547 |
|
| 2009 |
Hamon F, Prié G, Lecornué F, Papot S. Cyanuric chloride: an efficient reagent for the Lossen rearrangement Tetrahedron Letters. 50: 6800-6802. DOI: 10.1016/J.Tetlet.2009.09.115 |
0.319 |
|
| 2008 |
Thomas M, Clarhaut J, Tranoy-Opalinski I, Gesson JP, Roche J, Papot S. Synthesis and biological evaluation of glucuronide prodrugs of the histone deacetylase inhibitor CI-994 for application in selective cancer chemotherapy. Bioorganic & Medicinal Chemistry. 16: 8109-16. PMID 18692397 DOI: 10.1016/J.Bmc.2008.07.048 |
0.599 |
|
| 2008 |
Tranoy-Opalinski I, Fernandes AE, Thomas M, Gesson JP, Papot S. Design of self-immolative linkers for tumour-activated prodrug therapy Anti-Cancer Agents in Medicinal Chemistry. 8: 618-637. DOI: 10.2174/1871520610808060618 |
0.344 |
|
| 2007 |
Thomas M, Gesson JP, Papot S. First O-glycosylation of hydroxamic acids. The Journal of Organic Chemistry. 72: 4262-4. PMID 17465568 DOI: 10.1021/Jo0701839 |
0.595 |
|
| 2007 |
Thomas M, Rivault F, Tranoy-Opalinski I, Roche J, Gesson JP, Papot S. Synthesis and biological evaluation of the suberoylanilide hydroxamic acid (SAHA) beta-glucuronide and beta-galactoside for application in selective prodrug chemotherapy. Bioorganic & Medicinal Chemistry Letters. 17: 983-6. PMID 17157009 DOI: 10.1016/J.Bmcl.2006.11.042 |
0.604 |
|
| 2007 |
Papot S, Thomas M, Gesson J. Efficient Regio- and Stereoselective Synthesis of 1-β-O-Glucuronyl Carbamates and Carbonates from Unprotected 1,2,3,4-Hydroxyl Glucuronates Synlett. 2007: 1966-1968. DOI: 10.1055/S-2007-984534 |
0.593 |
|
| 2007 |
Thomas M, Gesson J, Papot S. Efficient Regio- and Stereoselective Synthesis of 1-β-O-Glucuronyl Carbamates and Carbonates from Unprotected 1,2,3,4-Hydroxyl Glucuronates. Cheminform. 38. DOI: 10.1002/chin.200750198 |
0.558 |
|
| 2006 |
Fernandes A, Marrot J, Gesson J, Papot S. A new simple and convenient method for the synthesis of substituted 2,6,9-trioxabicyclo[3.3.1]-nona-3,7-dienes from arylmalondialdehydes Tetrahedron Letters. 47: 5961-5964. DOI: 10.1016/J.TETLET.2006.06.043 |
0.563 |
|
| 2006 |
Fernandes A, Marrot J, Gesson J, Papot S. A New Simple and Convenient Method for the Synthesis of Substituted 2,6,9-Trioxabicyclo[3.3.1]-nona-3,7-dienes from Arylmalondialdehydes. Cheminform. 37. DOI: 10.1016/J.Tetlet.2006.06.043 |
0.6 |
|
| 2005 |
Combaud D, Thomas M, Papot S, Gesson J. Synthesis and Evaluation of p-Nitrophenylβ-D-Glucopyranosiduronic Analogues as New Triggers for β-Glucuronidase Mediated Prodrug Mono- Therapy Letters in Drug Design & Discovery. 2: 631-637. DOI: 10.2174/157018005774717271 |
0.571 |
|
| 2003 |
Papot S, Tranoy I, Tillequin F, Florent JC, Gesson JP. Design of selectively activated anticancer prodrugs: elimination and cyclization strategies. Current Medicinal Chemistry. Anti-Cancer Agents. 2: 155-85. PMID 12678742 DOI: 10.2174/1568011023354173 |
0.583 |
|
| 2002 |
Papot S, Rivault F, Tranoy I, Gesson J. Synthesis and β-Glucuronidase Mediated Cleavage of an Alcohol Prodrug Incorporating a Double Spacer Moiety Synlett. 2002: 0164-0166. DOI: 10.1055/S-2002-19327 |
0.581 |
|
| 2001 |
Nicolas LB, Pinoteau W, Papot S, Routier S, Guillaumet G, Mortaud S. Aggressive behavior induced by the steroid sulfatase inhibitor COUMATE and by DHEAS in CBA/H mice. Brain Research. 922: 216-22. PMID 11743952 DOI: 10.1016/S0006-8993(01)03171-7 |
0.364 |
|
| 2001 |
Maguire AR, Plunkett SJ, Papot S, Clynes M, O'Connor R, Touhey S. Synthesis of indomethacin analogues for evaluation as modulators of MRP activity. Bioorganic & Medicinal Chemistry. 9: 745-62. PMID 11310610 DOI: 10.1016/S0968-0896(00)00292-3 |
0.492 |
|
| 2001 |
Papot S, Combaud D, Bosslet K, Gerken M, Czech J, Gesson JP. Synthesis and cytotoxic activity of a glucuronylated prodrug of nornitrogen mustard. Bioorganic & Medicinal Chemistry Letters. 10: 1835-7. PMID 10969980 DOI: 10.1016/S0960-894X(00)00353-X |
0.631 |
|
| 2001 |
Maguire AR, Papot S, Ford A, Touhey S, O'Connor R, Clynes M. Enantioselective Synthesis of Sulindac Synlett. 2001: 0041-0044. DOI: 10.1055/S-2001-9722 |
0.329 |
|
| 1999 |
Papot S, Combaud D, Gesson JP. A new spacer group derived from arylmalonaldehydes for glucuronylated prodrugs. Bioorganic & Medicinal Chemistry Letters. 8: 2545-8. PMID 9873577 DOI: 10.1016/S0960-894X(98)00454-5 |
0.615 |
|
| 1999 |
Papot S, Bachmann C, Combaud D, Gesson J. Study of biscarbamates derived from 2-aminobenzylamines as models for alcohol prodrugs Tetrahedron. 55: 4699-4708. DOI: 10.1016/S0040-4020(99)00139-8 |
0.57 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2019 |
Viricel W, Fournet G, Beaumel S, Perrial E, Papot S, Dumontet C, Joseph B. Monodisperse polysarcosine-based highly-loaded antibody-drug conjugates. Chemical Science. 10: 4048-4053. PMID 31015945 DOI: 10.1039/C9Sc00285E |
0.297 |
|
| 2015 |
Bensalma S, Chadeneau C, Legigan T, Renoux B, Gaillard A, de Boisvilliers M, Pinet-Charvet C, Papot S, Muller JM. Evaluation of cytotoxic properties of a cyclopamine glucuronide prodrug in rat glioblastoma cells and tumors. Journal of Molecular Neuroscience : Mn. 55: 51-61. PMID 25280457 DOI: 10.1007/S12031-014-0395-3 |
0.289 |
|
| 2016 |
Rubio S, Clarhaut J, Péraudeau E, Vincenzi M, Soum C, Rossi F, Guillon J, Papot S, Ronga L. Diminished oligomerization in the synthesis of new anti-angiogenic cyclic peptide using solution instead of solid-phase cyclization. Biopolymers. 106: 368-75. PMID 26832831 DOI: 10.1002/Bip.22814 |
0.288 |
|
| 2010 |
Chevalier S, Goupille C, Mahéo K, Domingo I, Dussiau C, Renoux B, Bougnoux P, Papot S. Dietary docosahexaenoic acid proposed to sensitize breast tumors to locally delivered drug Clinical Lipidology. 5: 233-243. DOI: 10.2217/Clp.10.12 |
0.282 |
|
| 2012 |
Legigan T, Clarhaut J, Tranoy-Opalinski I, Monvoisin A, Renoux B, Thomas M, Le Pape A, Lerondel S, Papot S. Innentitelbild: The First Generation of β-Galactosidase-Responsive Prodrugs Designed for the Selective Treatment of Solid Tumors in Prodrug Monotherapy (Angew. Chem. 46/2012) Angewandte Chemie. 124: 11556-11556. DOI: 10.1002/Ange.201207805 |
0.28 |
|
| 2012 |
Legigan T, Clarhaut J, Tranoy-Opalinski I, Monvoisin A, Renoux B, Thomas M, Le Pape A, Lerondel S, Papot S. Inside Cover: The First Generation of β-Galactosidase-Responsive Prodrugs Designed for the Selective Treatment of Solid Tumors in Prodrug Monotherapy (Angew. Chem. Int. Ed. 46/2012) Angewandte Chemie International Edition. 51: 11392-11392. DOI: 10.1002/Anie.201207805 |
0.279 |
|
| 2011 |
Grinda M, Clarhaut J, Tranoy-Opalinski I, Renoux B, Monvoisin A, Cronier L, Papot S. A heterodimeric glucuronide prodrug for cancer tritherapy: the double role of the chemical amplifier. Chemmedchem. 6: 2137-41. PMID 21815268 DOI: 10.1002/Cmdc.201100355 |
0.276 |
|
| 2011 |
Grinda M, Clarhaut J, Tranoy-Opalinski I, Renoux B, Monvoisin A, Cronier L, Papot S. Inside Cover: A Heterodimeric Glucuronide Prodrug for Cancer Tritherapy: the Double Role of the Chemical Amplifier (ChemMedChem 12/2011) Chemmedchem. 6: 2114-2114. DOI: 10.1002/Cmdc.201190053 |
0.276 |
|
| 2013 |
Clarhaut J, Fraineau S, Guilhot J, Peraudeau E, Tranoy-Opalinski I, Thomas M, Renoux B, Randriamalala E, Bois P, Chatelier A, Monvoisin A, Cronier L, Papot S, Guilhot F. A galactosidase-responsive doxorubicin-folate conjugate for selective targeting of acute myelogenous leukemia blasts. Leukemia Research. 37: 948-55. PMID 23726264 DOI: 10.1016/J.Leukres.2013.04.026 |
0.275 |
|
| 2019 |
Thomas M, Alsarraf J, Araji N, Tranoy-Opalinski I, Renoux B, Papot S. The Lossen rearrangement from free hydroxamic acids. Organic & Biomolecular Chemistry. PMID 31090777 DOI: 10.1039/C9Ob00789J |
0.275 |
|
| 2009 |
Fernandes A, Viterisi A, Coutrot F, Potok S, Leigh DA, Aucagne V, Papot S. Rotaxane-based propeptides: protection and enzymatic release of a bioactive pentapeptide Angewandte Chemie - International Edition. 48: 6443-6447. PMID 19637268 DOI: 10.1002/Anie.200903215 |
0.274 |
|
| 2016 |
Pairault N, Barat R, Tranoy-Opalinski I, Renoux B, Thomas M, Papot S. Rotaxane-based architectures for biological applications Comptes Rendus Chimie. 19: 103-112. DOI: 10.1016/J.Crci.2015.05.012 |
0.27 |
|
| 2012 |
Roux JL, Gallard H, Croué JP, Papot S, Deborde M. NDMA formation by chloramination of ranitidine: kinetics and mechanism. Environmental Science & Technology. 46: 11095-103. PMID 22967139 DOI: 10.1021/Es3023094 |
0.269 |
|
| 2012 |
Geffroy-Rodier C, Buch A, Sternberg R, Papot S. Gas chromatography-mass spectrometry of hexafluoroacetone derivatives: First time utilization of a gaseous phase derivatizing agent for analysis of extraterrestrial amino acids. Journal of Chromatography. A. 1245: 158-66. PMID 22633064 DOI: 10.1016/J.Chroma.2012.04.062 |
0.268 |
|
| 2012 |
Fernandes A, Viterisi A, Aucagne V, Leigh DA, Papot S. Second generation specific-enzyme-activated rotaxane propeptides Chemical Communications. 48: 2083-2085. PMID 22227715 DOI: 10.1039/C2Cc17458H |
0.264 |
|
| 2017 |
Galons H, Barraja P, Papot S. Editorial - Current advances in cancer research: Therapeutics, Targets, and Chemical Biology. European Journal of Medicinal Chemistry. 142: 1. PMID 29153409 DOI: 10.1016/J.Ejmech.2017.11.020 |
0.259 |
|
| 2015 |
Gharbi A, Legigan T, Humblot V, Papot S, Berjeaud JM. Surface functionalization by covalent immobilization of an innovative carvacrol derivative to avoid fungal biofilm formation. Amb Express. 5: 9. PMID 25852986 DOI: 10.1186/S13568-014-0091-2 |
0.256 |
|
| 2006 |
Compain P, Desvergnes V, Ollivier C, Robert F, Suzenet F, Barboiu M, Belmont P, Blériot Y, Bolze F, Bouquillon S, Bourguet E, Braida B, Constantieux T, Désaubry L, Dupont D, ... ... Papot S, et al. Future achemy: Account of the ESYOP experiment | Alchimies futures: Compte rendu de l'expérience ESYOP Comptes Rendus Chimie. 9: 127-140. DOI: 10.1016/J.Crci.2005.09.004 |
0.25 |
|
| 2011 |
Thomas M, Clarhaut J, Strale PO, Tranoy-Opalinski I, Roche J, Papot S. A galactosidase-responsive "trojan horse" for the selective targeting of folate receptor-positive tumor cells. Chemmedchem. 6: 1006-10. PMID 21442760 DOI: 10.1002/Cmdc.201100114 |
0.244 |
|
| 2020 |
Porte K, Riberaud M, Chatre R, Papot S, Taran F, Audisio D. Bioorthogonal reactions in animals. Chembiochem : a European Journal of Chemical Biology. PMID 32935888 DOI: 10.1002/Cbic.202000525 |
0.244 |
|
| 2017 |
Eddhif B, Lange J, Guignard N, Batonneau Y, Clarhaut J, Papot S, Geffroy-Rodier C, Poinot P. Study of a novel agent for TCA precipitated proteins washing - comprehensive insights into the role of ethanol/HCl on molten globule state by multi-spectroscopic analyses. Journal of Proteomics. 173: 77-88. PMID 29191748 DOI: 10.1016/J.Jprot.2017.11.016 |
0.229 |
|
| 2019 |
Brissonnet Y, Compain G, Renoux B, Krammer E, Daligault F, Deniaud D, Papot S, Gouin SG. Monitoring glycosidase activity for clustered sugar substrates, a study on β-glucuronidase Rsc Advances. 9: 40263-40267. DOI: 10.1039/C9Ra08847D |
0.229 |
|
| 2018 |
Eddhif B, Guignard N, Batonneau Y, Clarhaut J, Papot S, Geffroy-Rodier C, Poinot P. TCA precipitation and ethanol/HCl single-step purification evaluation: One-dimensional gel electrophoresis, bradford assays, spectrofluorometry and Raman spectroscopy data on HSA, Rnase, lysozyme - Mascots and Skyline data. Data in Brief. 17: 938-953. PMID 29876449 DOI: 10.1016/J.Dib.2018.01.095 |
0.224 |
|
| 2023 |
Péraudeau E, Renoux B, Emambux S, Poinot P, Châtre R, Thoreau F, Riss Yaw B, Tougeron D, Clarhaut J, Papot S. Combination of Targeted Therapies for Colorectal Cancer Treatment. Molecular Pharmaceutics. 20: 4537-4545. PMID 37579031 DOI: 10.1021/acs.molpharmaceut.3c00224 |
0.224 |
|
| 2006 |
Compain P, Desvergnes V, Ollivier C, Robert F, Suzenet F, Barboiu M, Belmont P, Blériot Y, Bolze F, Bouquillon S, Bourguet E, Braida B, Constantieux T, Désaubry L, Dupont D, ... ... Papot S, et al. Looking forward: A glance into the future of organic chemistry New Journal of Chemistry. 30: 823-831. DOI: 10.1039/B601837H |
0.216 |
|
| 2023 |
Châtre R, Blochouse E, Eid R, Djago F, Lange J, Tarighi M, Renoux B, Sobilo J, Le Pape A, Clarhaut J, Geffroy C, Opalinski I, Tuo W, Papot S, Poinot P. Induced-volatolomics for the design of tumour activated therapy. Chemical Science. 14: 4697-4703. PMID 37181780 DOI: 10.1039/d2sc06797h |
0.214 |
|
| 2020 |
Pairault N, Bessaguet A, Barat R, Frédéric L, Pieters G, Crassous J, Opalinski I, Papot S. Diastereoselective synthesis of [1]rotaxanes an active metal template strategy. Chemical Science. 12: 2521-2526. PMID 34164020 DOI: 10.1039/d0sc05369d |
0.211 |
|
| 2001 |
Maguire AR, Papot S, Ford A, Touhey S, O'Connor R, Clynes M. ChemInform Abstract: Enantioselective Synthesis of Sulindac. Cheminform. 32: no-no. DOI: 10.1002/CHIN.200117096 |
0.209 |
|
| 2013 |
Huguet M, Deborde M, Papot S, Gallard H. Oxidative decarboxylation of diclofenac by manganese oxide bed filter. Water Research. 47: 5400-8. PMID 23850215 DOI: 10.1016/J.Watres.2013.06.016 |
0.206 |
|
| 2022 |
Plumet C, Châtre R, Djago F, Péraudeau E, Blancart-Remaury Q, Clarhaut J, Geffroy C, Said Mohamed A, Opalinski I, Renoux B, Poinot P, Papot S. A β-Cyclodextrin-Albumin Conjugate for Enhancing Therapeutic Efficacy of Cytotoxic Drugs. Bioconjugate Chemistry. 33: 1138-1144. PMID 35613473 DOI: 10.1021/acs.bioconjchem.2c00182 |
0.19 |
|
| 2023 |
Madegard L, Girard M, Yaw BR, Porte K, Audisio D, Papot S, Taran F. Bioorthogonal Drug Release from Nanometric Micelles in Living Cells. Chemistry (Weinheim An Der Bergstrasse, Germany). e202301359. PMID 37350524 DOI: 10.1002/chem.202301359 |
0.181 |
|
| 2022 |
Hauguel C, Ducellier S, Provot O, Ibrahim N, Lamaa D, Balcerowiak C, Letribot B, Nascimento M, Blanchard V, Askenatzis L, Levaique H, Bignon J, Baschieri F, Bauvais C, Bollot G, ... ... Papot S, et al. Design, synthesis and biological evaluation of quinoline-2-carbonitrile-based hydroxamic acids as dual tubulin polymerization and histone deacetylases inhibitors. European Journal of Medicinal Chemistry. 240: 114573. PMID 35797900 DOI: 10.1016/j.ejmech.2022.114573 |
0.161 |
|
| 2019 |
Brissonnet Y, Compain G, Renoux B, Krammer EM, Daligault F, Deniaud D, Papot S, Gouin SG. Monitoring glycosidase activity for clustered sugar substrates, a study on β-glucuronidase. Rsc Advances. 9: 40263-40267. PMID 35542663 DOI: 10.1039/c9ra08847d |
0.159 |
|
| 2010 |
Hamon F, Prie G, Lecornue F, Papot S. ChemInform Abstract: Cyanuric Chloride: An Efficient Reagent for the Lossen Rearrangement. Cheminform. 41: no-no. DOI: 10.1002/CHIN.201011035 |
0.156 |
|
| 2021 |
Aucagne V, Abboud SA, Amoura M, Madinier JB, Renoux B, Papot S, Piller V. Enzyme-cleavable linkers for protein chemical synthesis through solid-phase ligations. Angewandte Chemie (International Ed. in English). PMID 34097786 DOI: 10.1002/anie.202103768 |
0.152 |
|
| 2020 |
Raes F, Badiane SM, Renoux B, Papot S, Lerondel S, Le Pape A. Development of an embedded multimodality imaging platform for onco-pharmacology using a smart anticancer prodrug as an example. Scientific Reports. 10: 2661. PMID 32060400 DOI: 10.1038/s41598-020-59561-8 |
0.145 |
|
| 2021 |
Plumet C, Mohamed AS, Vendeuvre T, Renoux B, Clarhaut J, Papot S. Cell-cell interactions non-covalent click chemistry. Chemical Science. 12: 9017-9021. PMID 34276929 DOI: 10.1039/d1sc01637g |
0.13 |
|
| 2012 |
Bensalma S, Chadeneau C, Renoux B, Charvet C, Papot S, Muller J. 199 Cytotoxic Activity of a Cyclopamine Glucuronide Prodrug Against Glioblastoma Cells European Journal of Cancer. 48: S49. DOI: 10.1016/S0959-8049(12)70896-1 |
0.124 |
|
| 2022 |
Amarsy I, Papot S, Gasser G. Stimuli-Responsive Metal Complexes for Biomedical Applications. Angewandte Chemie (International Ed. in English). PMID 35781763 DOI: 10.1002/anie.202205900 |
0.122 |
|
| 2022 |
Bessaguet A, Blancart-Remaury Q, Poinot P, Opalinski I, Papot S. Stimuli-Responsive Catenane-Based Catalysts. Angewandte Chemie (International Ed. in English). 62: e202216787. PMID 36478644 DOI: 10.1002/anie.202216787 |
0.101 |
|
| 2023 |
Blochouse E, Eid R, Araji N, Tuo W, Châtre R, Papot S, Lévêque N, Thuillier R, Poinot P. VOC-Based Probes, a New Set of Analytical Tools to Monitor Patient Health from Blood Sample. Proof of Concept on Tracking COVID-19 Infection. Analytical Chemistry. PMID 37405898 DOI: 10.1021/acs.analchem.3c01732 |
0.1 |
|
| 2020 |
Lange J, Djago F, Eddhif B, Remaury QB, Ruf A, Leitner NKV, Hendecourt LLS, Danger G, Rodier CG, Papot S, Poinot P. A Novel Proteomics-Based Strategy for the Investigation of Peptide Sequences in Extraterrestrial Samples. Journal of Proteome Research. PMID 33078610 DOI: 10.1021/acs.jproteome.0c00700 |
0.099 |
|
| 2023 |
Baron L, Hadjerci J, Thoidingjam L, Plays M, Bucci R, Morris N, Müller S, Sindikubwabo F, Solier S, Cañeque T, Colombeau L, Blouin CM, Lamaze C, Puisieux A, Bono Y, ... ... Papot S, et al. PSL Chemical Biology Symposia Third Edition: A Branch of Science in its Explosive Phase. Chembiochem : a European Journal of Chemical Biology. e202300093. PMID 36942862 DOI: 10.1002/cbic.202300093 |
0.069 |
|
| 2015 |
Gharbi A, Legigan T, Humblot V, Papot S, Imbert C, Berjeaud JM. Erratum to: Surface functionalization by covalent immobilization of an innovative carvacrol derivative to avoid fungal biofilm formation. Amb Express. 5: 141. PMID 26292637 DOI: 10.1186/s13568-015-0141-4 |
0.058 |
|
| 2021 |
Puente AR, Bessaguet A, Pairault N, Pieters G, Crassous J, Polavarapu PL, Opalinski I, Papot S. Absolute configuration of a [1]rotaxane determined from vibrational and electronic circular dichroism spectra. Chirality. 33: 773-782. PMID 34590354 DOI: 10.1002/chir.23365 |
0.022 |
|
| Hide low-probability matches. |